CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 113 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $60,444 | -12.4% | 10,350 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $69,000 | +56.8% | 10,350 | -0.5% | 0.01% | +60.0% |
| Q2 2022 | $44,000 | +25.7% | 10,400 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $35,000 | +6.1% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -44.1% | 10,400 | -25.2% | 0.00% | -50.0% |
| Q3 2021 | $59,000 | 0.0% | 13,900 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $59,000 | +3.5% | 13,900 | +21.9% | 0.01% | 0.0% |
| Q1 2021 | $57,000 | +46.2% | 11,400 | +185.0% | 0.01% | +20.0% |
| Q3 2020 | $39,000 | 0.0% | 4,000 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $39,000 | 0.0% | 4,000 | -9.1% | 0.01% | -25.0% |
| Q1 2020 | $39,000 | -15.2% | 4,400 | -12.0% | 0.01% | 0.0% |
| Q4 2019 | $46,000 | +58.6% | 5,000 | 0.0% | 0.01% | +33.3% |
| Q3 2019 | $29,000 | +31.8% | 5,000 | +163.2% | 0.01% | +20.0% |
| Q2 2019 | $22,000 | 0.0% | 1,900 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $22,000 | -4.3% | 1,900 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $23,000 | -14.8% | 1,900 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $27,000 | -12.9% | 1,900 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $31,000 | – | 1,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |